Companies
-
Sparse field for MA Board race as MDs opt out
- Mon Aug 24
Nominations for Medicines Australia Board vacancies are opened and while many big names say they won’t run, a couple have expressed some interest.
Read more -
Telix APAC boss predicts local pressure, MFN workarounds
- Fri Aug 21
Telix VP Adrian Dunstan unveils ways companies hope to skirt US reference pricing while predicting growing pressure for country leaders to launch successfully, or be told to leave.
Read more -
ANZ pharmas strengthen leadership teams
- Fri Aug 21
Biogen, MSD and Lundbeck have taken on senior people this month as top executives move around and companies have their choice of talent.
Read more -
Sobi tops with rare disease patients
- Fri Aug 21
Beats Roche, Boehringer to win best reputation among rare disease patients, but it is Viatris’ meteoric rise that makes it one to watch.
Read more -
Indian PR giant buys control of SenateSHJ
- Fri Aug 21
Adfactors PR acquires a majority stake in SenateSHJ, a major provider of media and corporate affairs services to the ANZ pharma and MedTech sectors.
Read more -
DBG Health names Greg Hunt as Board director
- Wed Aug 12
The company put out a statement announcing the former Health Minister’s directorship, but it seems Greg Hunt has been a DBG director for some time.
Read more -
BeOne forges alliance with Revolution Medicines
- Wed Aug 12
After capturing attention with its pancreatic cancer therapy, Revolution Medicines is teaming up with BeOne to advance RAS‑targeted cancer therapies and expand access in Asia.
Read more -
Adam Wyldeck starts new role in the US
- Mon Aug 10
One of Australia’s most successful corporate affairs exports, Adam Wyldeck left J&J last month for an exciting senior role with AstraZeneca. He tells MedNews why he wants to stay in the US.
Read more